ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AG01 | G | Sodium Valproate - 500mg | 528 | 208315/02 | CONVULEX RETARD | 500mg | 50 | Tablet, prolonged release | Oral | Bellapharma S.A.R.L. | GL Pharma GmbH | Austria | 423,310 L.L | 23.08 | A1 | GL Pharma GmbH | Austria | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AG01 | B | Valproic acid - 145mg, Sodium Valproate - 333mg | 2987 | 26876 | DEPAKINE CHRONO L.P. | 500mg | 30 | Tablet, coated, scored, prolonged release | Oral | Mersaco | Sanofi Winthrop Industrie | France | 362,837 L.L | 23.08 | A1 | Sanofi Aventis | France | 12/12/20 | 0 |
N03AG01 | G | Sodium valproate - 500mg | 8159 | 46515/1 | VALPROATE DE SODIUM ARROW LP | 500mg | 30 | Tablet, coated, scored, prolonged release | Oral | Darapharma S.A.L. | Dragenopharm Apotheker Puschl GmbH | Germany | 253,986 L.L | 23.08 | A1 | Arrow Génériques | France | 12/12/20 | 0 |
N03AG01 | G | Sodium valproate - 333mg, Valproic acid - 145mg | 9126 | 43415/1 | VILAPRO CHRONO 500 | 30 | Tablet, film coated, prolonged release | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 217,702 L.L | 23.08 | A1 | Dar Al Dawa Development & Investment Co Ltd | Jordan | 12/12/20 | 0 |